Alessandro Pedercini

Dr. Alessandro Pedercini

University of Minnesota
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 November 2020 in Antibiotics
Verified
Journal Article
Open access
PDF file
Ioannis KormasIoannis Kormas
Ioannis Kormas
CPChantal Pedercini
Chantal Pedercini
APAlessandro Pedercini
Alessandro Pedercini
MRMichail Raptopoulos
Michail Raptopoulos
HAHatem Alassy
Hatem Alassy
LWLarry Wolff
Larry Wolff
Since the use of dental implants is continuously increasing, it is imperative for dental practitioners to understand the nature and treatment of peri-implant diseases. The purpose of this manuscript is to comprehensively review peri-implant diseases, their characteristics, as well as their non-surgical and surgical treatment. To that end, the current literature was searched and a narrative review was conducted. It is essential that the case definitions described in the 2017 World Workshop on the Classification of Periodontal and Peri-implant Diseases and Conditions are used to diagnose and classify peri-implant health, peri-implant mucositis and peri-implantitis. While recent epidemiologic studies on peri-implant diseases exist, there is great heterogeneity in the definition of these conditions. Several risk factors and indicators are reported in the literature, with smoking and diabetes being the most universally accepted. In peri-implant mucositis, non-surgical treatment seems to be sufficient. However, for the treatment of peri-implantitis, a surgical approach, which includes open-flap debridement, apically positioned flap and guided bone regeneration, is considered more appropriate. A great variety of adjuncts to mechanical treatment have been reported with controversial results. Finally, studies comparing results from different peri-implantitis treatments are warranted in randomized controlled clinical trials in order to provide stronger evidence-based approaches.

1 June 2021 in Frontiers of Oral and Maxillofacial Medicine
Verified
Journal Article
Open access
PDF file
HAHatem Alassy
Hatem Alassy
JPJohn A. Pizarek
John A. Pizarek
IKIoannis Kormas
Ioannis Kormas
APAlessandro Pedercini
Alessandro Pedercini
LWLarry F. Wolff
Larry F. Wolff
Periodontal and peri-implant diseases are of rising concern due to their increasing prevalence, potential complications and financial consequences. Etiologic factors primarily are putative microorganisms while therapy involves mechanical debridement of the dental plaque biofilm. This treatment is performed non-surgically or surgically. Due to the diversity of periodontal and peri-implant diseases and conditions, practitioners seek adjuvants to improve therapeutic outcomes and limit the likelihood of residual or refractory disease. Antimicrobials may improve therapeutic success by altering the local pathogenic microflora and limiting the systemic spread of opportunistic infections. The use of antimicrobial adjuncts in dentistry is controversial, and there is a need to assess their validity in order to improve the success rates of periodontal and implant therapy whilst minimizing complications or adverse effects. This review aims to provide a summary of the current status of antimicrobial use for periodontal and peri-implant disease management. Adjunctive therapy may include systemic antibiotics, local antimicrobials, supra and sub-gingival antimicrobial irrigants, antimicrobial oral rinses, antiplaque and anti-calculus agents, photodynamic and laser therapies. Periodontal and peri-implant conditions are detailed, and adjunct antimicrobial options are summarized and their benefits are weighed against their potential side-effects. We proposed a standardized protocol for the adjunctive use of local and systemic antimicrobials in the management of periodontal or peri-implant diseases and conditions.

17 September 2021 in Molecules
Verified
Journal Article
Open access
PDF file
SEShorouk Elnagdy
Shorouk Elnagdy
MRMichail Raptopoulos
Michail Raptopoulos
Ioannis KormasIoannis Kormas
Ioannis Kormas
APAlessandro Pedercini
Alessandro Pedercini
LWLarry Wolff
Larry Wolff
Despite many discoveries over the past 20 years regarding the etiopathogenesis of periodontal and peri-implant diseases, as well as significant advances in our understanding of microbial biofilms, the incidence of these pathologies continues to rise. For this reason, it was clear that other strategies were needed to eliminate biofilms. In this review, the literature database was searched for studies on locally delivered synthetic agents that exhibit anti-biofilm properties and their potential use in the treatment of two important oral diseases: periodontitis and peri-implantitis.

29 August 2022 in Membranes
Verified
Journal Article
Open access
PDF file
Ioannis KormasIoannis Kormas
Ioannis Kormas
APAlessandro Pedercini
Alessandro Pedercini
HAHatem Alassy
Hatem Alassy
LWLarry Wolff
Larry Wolff
The use of biocompatible membranes in periodontal and oral surgery is an important part of regeneration. Over the years, several different membranes have been developed, ranging from non-resorbable membranes that have to be removed in a separate procedure, to collagen membranes that completely resorb on their own, thus avoiding the need for a second surgery. Autogenous membranes are becoming increasingly popular in more recent years. These membranes can be used with a great variety of techniques in the four main hard tissue regenerative procedures: guided tissue regeneration, alveolar ridge preservation, guided bone regeneration and sinus floor augmentation. A review of the literature was conducted in order to identify the most commonly used membranes in clinical practice, as well as the most promising ones for regeneration procedures in the future. The information provided in this review may serve as a guide to clinicians, in order to select the most applicable membrane for the clinical case treated as the correct choice of materials may be critical in the procedure’s success.

1 March 2021 in Australian Dental Journal
Verified
Journal Article
Closed access
PDF file
APAlessandro Pedercini
Alessandro Pedercini
DWDf Weitz
Df Weitz
JHJd Heyse
Jd Heyse
CPC Pedercini
C Pedercini
IKI Kormas
I Kormas
SMSB McClanahan
SB McClanahan

10 July 2021 in Clinical Advances in Periodontics
Verified
Journal Article
Closed access
PDF file
Ioannis KormasIoannis Kormas
Ioannis Kormas
APAlessandro Pedercini
Alessandro Pedercini
DPDavid B. Paulson
David B. Paulson
MCMassimo Costalonga
Massimo Costalonga